Search
01/07/2021
Covid-19, hypercoagulability and risk of mortality in schizophrenia
Garcia-Ribera, C, Carrasco, M, Ruiz-Ripoll, A. Covid-19, hypercoagulability and risk of mortality in schizophrenia. ACTAS ESPANOLAS DE PSIQUIATRIA. 2021; 49(4)DOI:. PMID:34195973. IF:1.667(Q4/9D).
01/10/2025
Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations
Marzo, C, Solanich, T, Tassies, D, Pina, E, Rebollo, MA, Gallardo, E, Serradell, S, Merino, M, Carrasco, M, Tugues, A. Consensus on the Management of the Clinical Challenges of Venous Thromboembolism in Special Situations. THROMBOSIS AND HAEMOSTASIS. 2025; 125(10)DOI:10.1055/a-2595-1811. PMID:40359988. IF:4.300(Q1/2D).
09/05/2025
Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus
Berrueco, R, Soto, I, Bastida, JM, Villas, JMC, de Cos, C, Haya, S, García, FS, Arranz, JM. Patient-Centred Management of Well-Controlled Haemophilia: Obtaining Opinions and Definitions Through a Delphi Consensus. Journal of Clinical Medicine. 2025; 14(10)DOI:10.3390/jcm14103300. PMID:40429300. IF:2.900(Q1/2D).
29/01/2025
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project
Hernández-Rodríguez, J, Martínez-Valle, F, Acebes, X, Alerany, C, Antón, J, Calvo, G, Corral, M, Cruz, J, Mangues-Bafalluy, MA, Mateo, J, Rivera, J, Salazar, A, Francisco, R, Mallol, C, Reig-Viader, R, Tigri-Santiña, A, Ricart, A, Palau, F. Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project. Orphanet Journal of Rare Diseases. 2025; 20(1)DOI:10.1186/s13023-024-03518-x. PMID:39875900. IF:3.500(Q2/4D).
01/01/2025
Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study
Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).
01/01/2025
Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome
Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).